Clinical Performance of GYNECARE PROSIMA* Pelvic Floor Repair System for Symptomatic Pelvic Organ Prolapse
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the safety and effectiveness of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Device in Women with Symptomatic Pelvic Organ Prolapse.
| Condition | Intervention |
|---|---|
|
Pelvic Organ Prolapse Stage II-III |
Procedure: Procedure: GYNECARE PROSIMA* Pelvic Floor Repair System |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective, Multicenter Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Symptomatic POP-Q Stage II-III Pelvic Organ Prolapse |
- Anatomical improvement according to POP-Q score. [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
- Anatomical improvement according to POP-Q score. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Anatomical improvement according to POP-Q score. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
- Anatomical improvement according to POP-Q score. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Anatomical improvement according to POP-Q score. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- Hospital data including operative time, estimated blood loss, length of stay, maximum temperature, time of voiding recovery. [ Time Frame: At discharge, an expected average of 5 days after operation. ] [ Designated as safety issue: Yes ]
- Pain score measured using Visual Analog Scale (VAS). [ Time Frame: 24 hours after surgery and postoperation visit at the 3-4 weeks. ] [ Designated as safety issue: Yes ]
- Discomfort of balloon removal, measured using VAS at time of removal. [ Time Frame: 24 hours after surgery. ] [ Designated as safety issue: Yes ]
- Subject discomfort of VSD by VAS. [ Time Frame: postoperation visit at 3-4 weeks. ] [ Designated as safety issue: Yes ]
- Presence/absence of complications (composite score) [ Time Frame: Up to 6 weeks. ] [ Designated as safety issue: Yes ]The occurrence (in the per-operative phase or within 6 weeks post-op) of at least one of the following: 1) bleeding complications; 2) infectious complications; 3) any wound caused by a surgeon movement: bladder, ureteral, or vascular injuries; 4)medical complications: deep vein thrombosis, pulmonary embolism and etc. Complications will be categorized using the Dindo surgical complication grading scale.
- Change from baseline in PFIQ-7 scores. [ Time Frame: 6 months, 12 months, 2 years and 3 years. ] [ Designated as safety issue: No ]
- In subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline). [ Time Frame: 6 months, 12 months, 2 years and 3 years. ] [ Designated as safety issue: No ]
- Subject global impression assessed on a 5 point Likert scale. [ Time Frame: 6 months, 12 months, 2 years and 3 years. ] [ Designated as safety issue: No ]
- Presence/absence of complications (composite score) [ Time Frame: Up to 3 years. ] [ Designated as safety issue: Yes ]Long-term negative outcomes of the surgical procedure will also be recorded until 3 years after surgery. For example, mesh erosion, de novo urinary incontinence, de novo dyspareunia and overall failure rate. Complications will be categorized using the Dindo surgical complication grading scale.
| Estimated Enrollment: | 150 |
| Study Start Date: | March 2011 |
| Estimated Study Completion Date: | March 2016 |
| Estimated Primary Completion Date: | March 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: PROSIMA group
Reconstructive surgeries with GYNECARE PROSIMA* were performed in all patients.
|
Procedure: Procedure: GYNECARE PROSIMA* Pelvic Floor Repair System
Perform surgery with GYNECARE PROSIMA* Pelvic Floor Repair System. Vaginal hysterectomy or mid-urethral sling procedure for incontinence could be performed concurrently.
|
Detailed Description:
The GYNECARE PROSIMA* system is a new technique and now available in China. It provides a simplified unanchored mesh repair, making surgery much simpler to perform and reduces the risk of the specific complications that may occur when tunneling devices beyond the pelvic cavity.
In clinical practice, many women have symptomatic prolapse, which requires surgical correction. They are relatively young, and therefore care more about the long-term outcomes and quality of life after procedure. The purpose of this multicenter and prospective study is to evaluate the effectiveness and safety of the GYNECARE PROSIMA* system in the treatment of symptomatic POP-Q Stage II-III pelvic organ prolapse.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Candidates with symptomatic pelvic organ prolapse of ICS POP-Q Stage II or III, suitable for surgical repair. Vaginal hysterectomy and mid-urethral sling procedures for incontinence may be performed concurrently.
- Age ≥ 18 years.
- Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires, and documents this agreement by signing the Ethics Committee approved informed consent.
Exclusion Criteria:
- Additional surgical intervention concurrent to the procedure (e.g. sacrocolpopexy, paravaginal repair, tubal sterilisation).
- Previous repair of pelvic organ prolapse involving insertion of mesh.
- Previous hysterectomy within 6 months of scheduled surgery.
- Experimental drug or experimental medical device within 3 months prior to the planned procedure.
- Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
- Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.
- History of chemotherapy or pelvic radiation therapy.
- Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma).
- Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia).
- Nursing or pregnant or intends future pregnancy.
- Chronic cough not well-controlled.
- BMI≥30.
- In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.
Contacts and Locations| Contact: Lan Zhu | 86-10-65296238 | zhu_julie@vip.sina.com |
| Contact: Juan Chen | 86-13521354364 | pumchcj@sina.com |
| China, Fujian | |
| Fujian Provincial Hospital | Active, not recruiting |
| Fuzhou, Fujian, China, 350001 | |
| The First Affiliated Hospital of Fujian Medical University | Active, not recruiting |
| Fuzhou, Fujian, China, 350005 | |
| Xiamen First Hospital Affiliated to Xiamen University | Recruiting |
| Xiamen, Fujian, China, 361004 | |
| Contact: Na-xuan Qiu 13906011647 qnx1106@sina.com | |
| Principal Investigator: Na-xuan Qiu | |
| China, Guangdong | |
| The First People's Hospital of Foshan | Not yet recruiting |
| Foshan, Guangdong, China, 528000 | |
| Contact: Gang Wang 86-13929928768 Wallace1971@163.com | |
| Principal Investigator: Gang Wang | |
| The First Hospital of Sun Yat-sen University | Active, not recruiting |
| Guangzhou, Guangdong, China, 510080 | |
| The First Affiliated Hospital of Guangzhou Medical College | Active, not recruiting |
| Guangzhou, Guangdong, China, 510120 | |
| Peking University Shenzhen Hospital | Recruiting |
| Shenzhen, Guangdong, China, 518036 | |
| Contact: Rui-fang Wu 86-13827433039 Wurf100@126.com | |
| Contact: Huan Li 86-13828700921 szbdlh@163.com | |
| Principal Investigator: Rui-fang Wu | |
| China, Heilongjiang | |
| The First Affiliated Hospital of Harbin Medical University | Active, not recruiting |
| Harbin, Heilongjiang, China, 150001 | |
| China, Hubei | |
| The Third Hospital of Wuhan | Active, not recruiting |
| Wuhan, Hubei, China, 430060 | |
| The People's Hospital of Hubei Provincial | Active, not recruiting |
| Wuhan, Hubei, China, 430060 | |
| China, Hunan | |
| The Second Hospital of Xiangya,Central South University | Recruiting |
| Changsha, Hunan, China, 410011 | |
| Contact: Guang-shi Tao 86-13574850167 taoguangshi@yahoo.com.cn | |
| Principal Investigator: Guang-shi Tao | |
| China, Jiangsu | |
| The First Hospital Affiliated to Nanjing Medical University | Active, not recruiting |
| Nanjing, Jiangsu, China, 210006 | |
| Wuxi Maternal and Child Health Hospital, Nanjing Medical University | Recruiting |
| Wuxi, Jiangsu, China, 214002 | |
| Contact: Jian Gong 86-13812074116 gongjianwx@126.com | |
| Principal Investigator: Jian Gong | |
| China, Liaoning | |
| Affiliated Shengjing Hospital of China Medical University | Recruiting |
| Shenyang, Liaoning, China, 110004 | |
| Contact: Zhi-jun Xia 86-13840118800 xiazhijunhosp2@sina.com | |
| Contact: Qing Hu 86-18940255559 huq@sj-hospital.org | |
| Principal Investigator: Zhi-jun Xia | |
| China, Shandong | |
| The Second Affiliated Hospital, Shandong University | Active, not recruiting |
| Jinan, Shandong, China, 250033 | |
| China, Sichuan | |
| The Fifth People' Hospital of Chengdu | Active, not recruiting |
| Chengdu, Sichuan, China, 611130 | |
| West China Hospital, Sichuan University | Recruiting |
| Chengdu, Sichuan, China, 610041 | |
| Contact: Hong Shen 86-18980601433 shen1177@163.com | |
| Principal Investigator: Hong Shen | |
| West China Second Hospital of Sichuan University | Active, not recruiting |
| Chengdu, Sichuan, China, 610041 | |
| Sichuan Provincial People's Hospital | Active, not recruiting |
| Chengdu, Sichuan, China, 610072 | |
| Mianyang Central Hospital | Recruiting |
| Mianyang, Sichuan, China, 621000 | |
| Contact: Yong Zhang 86-13808110138 Zhangyong1215@gmail.com | |
| Principal Investigator: Yong Zhang | |
| China | |
| Beijing Hospital | Active, not recruiting |
| Beijing, China, 100730 | |
| Peking Union Medical College Hospital | Recruiting |
| Beijing, China, 100730 | |
| Contact: Lan Zhu 86-10-65296238 zhu_julie@vip.sina.com | |
| Contact: Juan Chen 86-13521354364 pumchcj@sina.com | |
| Principal Investigator: Lan Zhu | |
| Beijing Chaoyang Hospital Affiliated to Capital University of Medical Sciences | Recruiting |
| Beijing, China, 100020 | |
| Contact: Zhenyu Zhang 86-13801237287 Zhenyuzhang2000@yahoo.com | |
| Contact: Hong Wang 86-13683690370 | |
| Principal Investigator: Zhenyu Zhang | |
| The First Affiliated Hospital of Chinese PLA General Hospital | Recruiting |
| Beijing, China, 100048 | |
| Contact: Yong-xian Lu 86-13520476024 Yongxianlu@sina.com | |
| Principal Investigator: Yong-xina Lu | |
| The First Hospital of Chongqing Medical University | Active, not recruiting |
| Chongqin, China, 400016 | |
| Principal Investigator: | Lan Zhu | Peking Union Medical College Hospital |
More Information
No publications provided
| Responsible Party: | Peking Union Medical College Hospital |
| ClinicalTrials.gov Identifier: | NCT01396122 History of Changes |
| Other Study ID Numbers: | pumch-gyn-02 |
| Study First Received: | July 13, 2011 |
| Last Updated: | December 25, 2012 |
| Health Authority: | China: Ministry of Health |
Additional relevant MeSH terms:
|
Prolapse Pelvic Organ Prolapse Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 23, 2013